Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

BAUSCH & LOMB PERSONAL HEALTH SECTOR FIRST-QUARTER SALES RISE 10%

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

BAUSCH & LOMB PERSONAL HEALTH SECTOR FIRST-QUARTER SALES RISE 10% to approximately $145 mil. Results for the sector reflected "incremental revenues attributable to the Curel and Soft Sense lines of skin care products acquired in June 1993, and significantly higher shipments of general eye care products in the U.S. and over-the-counter medication products in Europe," Bausch & Lomb reported.

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

UK MHRA Considers New Approach To Support Sponsors Throughout Clinical Trial Lifecycle

EU Biosimilar Filings, Opinions And Approvals

UK’s MHRA To Use AI In Regulatory Review Process & RWD Analysis

Bolar Exemption India Files: Roche Blocks Alleged Infringer Of Evrysdi Patent

See All
UsernamePublicRestriction

Register

PS082697

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By